Armata Pharmaceuticals, Inc. - 10-Q Filing

Armata Pharmaceuticals reports Q3 2026 financial results and details ongoing debt obligations with Innoviva Strategic Opportunities LLC.

SEC EDGAR ·

Tickers: $ARMP

Read the full article at SEC EDGAR

More Regulatory news